Overview
Seiichi Okabe practices in Tokyo, Japan. Mr. Okabe is rated as an Elite expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Multiple Myeloma, and Myelodysplastic Syndrome (MDS).
His clinical research consists of co-authoring 59 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 38 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Myelogenous Leukemia (CML)
- Distinguished
- LeukemiaMr. Okabe isDistinguished. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Okabe isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Okabe isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute PainMr. Okabe isExperienced. Learn about Acute Pain.
- Cerebral HypoxiaMr. Okabe isExperienced. Learn about Cerebral Hypoxia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaMr. Okabe isExperienced. Learn about Multiple Myeloma.